Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 14 results found. Search for [ Sandoz Inc ]

Results 1 to 14 of 14
BusinessToday.In
April 3, 2020
Aurobindo Pharma stock opened 10% lower at Rs 352.95 and hit an intra day high of 395 , signaling weak signs of recovery


BusinessToday.In
April 2, 2020
Stocks to watch today on April 3: Kilpest India, Cipla, TVS Motor, Aurobindo Pharma, JB Chemicals, AIMCO Pesticides among others are the top stocks to watch out for in Friday's trading session


PTI
New Delhi, November 24, 2019
Aurobindo Pharma's net debt decreased by $71 million quarter-on-quarter to $522 million at the end of September 2019


E Kumar Sharma
New Delhi, December 18, 2018
Leading Indian pharma company Dr Reddy's has still not been able to overcome the regulatory challenges. Its important Duvvada facility in Andhra has been under warning letter from the US drug regulator since 2015.


PTI
December 2, 2018



PTI
October 15, 2018



Reuters
New Delhi, September 6, 2018
The 131-year-old Sandoz unit was hurt by price pressure in the United States, prompting Novartis Chief Executive Officer Vas Narasimhan to sell the Sandoz unit.


BusinessToday.in
New Delhi, January 19, 2018
Private sector lender HDFC Bank became the first Indian bank to cross the Rs 5-lakh crore market capitalisation


E Kumar Sharma
November 3, 2017
The list includes names of some of India's leading pharmaceutical companies like Sun Pharma, Dr Reddy's, Glenmark and Aurobindo.


PTI
Hyderabad, August 11, 2014
According to Teva, it has received a Para-IV notice from the Indian drug maker over Copaxone, and the lawsuit may trigger a 30-month stay of FDA approval of Dr Reddy's Abbreviated New Drug Application.


E. Kumar Sharma
May 31, 2014
In the seven years since, Mylan Inc has invested around $3 billion on acquisitions in India. It now regards India not just as a global sourcing hub, but also as a market.


PTI
New Delhi, June 28, 2012
Drug firm Sandoz Inc has filed a petition with the USFDA asking the health regulator to withdraw 180-days marketing exclusivity granted to Ranbaxy Laboratories for a generic version of Nexium, a drug used to treat stomach ulcer.


Rahul Sachitana
September 2, 2009
After changing its focus from enzymes to biopharma, India's best-known biotech company wants to transform itself into a truly global company.


www.businesstoday.in
May 28, 2008
The sheer amount of manufacturing activity taking place in small towns of India is mindboggling. Shops are being set up at breakneck speed and there is massive expansion. Where are these clusters located, and can they really deliver on their promise? Here is what Business Today discovered.


PAGES 1 OF 1